Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This introductory paragraph highlights how yearly drawdown data for index funds reveals cyclic risk patterns and guides more resilient investment choices.
25,260 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Marvell Technology has surged dramatically, but can it keep delivering value for investors? This guide dives into the...
A hotter-than-expected inflation reading this week could push the Fed toward another rate hike, according to Fed Gove...
Nvidia has delivered one of the era's most dramatic stock ascents. But with such gains already in the price, can the ...
The Nasdaq led a tech-led rally as AI demand and solid jobs data improved sentiment. This analysis breaks down what m...
Chipmakers led U.S. equities higher, helping the S&P 500 reach a new close. This piece breaks down what moved markets...
Nvidia has built a fortress around AI-driven growth, but one number could alter the trajectory. This article breaks d...
When a fund sold $5.5 million of a regional bank, headlines lit up. But one big trade rarely tells the whole story. T...
A top Nomura strategist says equities are priced for chaos, but the odds of a sweeping market crash remain low as dat...
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
Investors often worry about a bear market under political changes. This thoughtful look at the likelihood bear market...
When Alphabet stock just crashed, investors hunted for real reasons beyond headlines. This guide breaks down the core...